Morris, Tessa A <br/><br/>
Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors.  [electronic resource] 

 -  Drugs  Aug 2019 
 - 1277-1286 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.1007/s40265-019-01164-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Blood-Brain Barrier--metabolism<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Crizotinib--analogs & derivatives<br/>Drug Resistance, Neoplasm<br/>Gene Rearrangement<br/>Humans<br/>Lung Neoplasms--diagnosis<br/>Molecular Targeted Therapy<br/>Mutation<br/>Permeability<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins--antagonists & inhibitors